Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Simian adenoviruses as vaccine vectors

Journal article

Morris SJ. et al, (2016), Future Virology, 11, 649 - 659

Laboratory-Scale Production of Replication-Deficient Adenovirus Vectored Vaccines

Chapter

Morris SJ. et al, (2016), Methods in Molecular Biology, 121 - 135

The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K

Journal article

Wright J. et al, (2015), Journal of Virology, 89, 7053 - 7063

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors

Journal article

Cottingham MG. et al, (2012), Biotechnology and Bioengineering, 109, 719 - 728

Adenovirus Late-Phase Infection Is Controlled by a Novel L4 Promoter

Journal article

Morris SJ. et al, (2010), Journal of Virology, 84, 7096 - 7104

Generation of Cell Lines to Complement Adenovirus Vectors using Recombination-Mediated Cassette Exchange

Journal article

Morris SJ. et al, (2010), BMC Biotechnology, 10, 92 - 92